XML 32 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Collaboration and License Agreements (Tables)
 6 Months Ended
Jun. 30, 2017
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Revenue from Collaboration and License Agreements

We have recognized revenue from our collaboration and license agreements as follows (in thousands):  

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

BMS and Pfizer

 

$

1,027

 

 

$

1,733

 

 

$

2,785

 

 

$

2,987

 

Daiichi Sankyo

 

 

2,012

 

 

 

1,297

 

 

 

4,194

 

 

 

4,681

 

Bayer and Janssen

 

 

538

 

 

 

807

 

 

 

1,336

 

 

 

4,115

 

Bayer

 

 

210

 

 

 

394

 

 

 

600

 

 

 

654

 

Other

 

 

—

 

 

—

 

 

 

—

 

 

 

52

 

Total collaboration and license revenue

 

$

3,787

 

 

$

4,231

 

 

$

8,915

 

 

$

12,489